
    
      Number of trial subjects=48 Investigational product=Ag85B - ESAT-6 + IC31 Dosage Group 1: TST
      negative, 50 µg antigen Group 2: TST negative, 50 µg antigen + fixed adjuvant Group 3: BCG
      vaccinated, 50 µg antigen + fixed adjuvant Group 4 : Latent TB, 50 µg antigen + fixed
      adjuvant Dosage volume 0.5 ml Administration Intramuscularly into deltoid muscle, alternate
      arms at day 0 (right) and day 56 (left).
    
  